Azara Controlled Substance Module provides tools to efficiently manage patients in treatment for substance use disorder, those at risk for developing disorders, and those with chronic pain through integrated registries, measures, and dashboards.

Key Features

Substance Use Disorder Management Comprehensive tracking and monitoring of at-risk populations

• Early identification of patients at risk for alcohol and substance misuse
• Identify at-risk patients based on being ordered an opioid medication
• Track and manage patients with known alcohol and opioid use disorders
• Monitor patients enrolled in office-based opioid treatment (OBOT) programs
• Monitor patients with active opioid treatment medications such as methadone
• Monitor concurrent use of Benzodiazepine and opioids

Chronic Pain Management Specialized tools for chronic pain patient populations

• Monitor patients who have chronic pain
• Assess pain management protocols and medication patterns
• Track outcomes and effectiveness of pain management interventions

Hepatitis C (HEP-C) Capabilities Comprehensive HEP-C cascade management

• Over 15 measures following the HEP-C cascade from screening to treatment to cure, including barriers to treatment
• Identify patient populations for screenings, diagnosis, and other risk factors
• Incorporate screenings and treatments into the DRVS Pre-Visit Planning report (PVP)
• Support patients through behavioral health and social determinants of health (SDOH) assessments
• Use dashboards to view at-risk and diagnosed populations as well as prevention and treatment program status
• Manage overlapping patient populations with other substance abuse and/or chronic pain conditions
• Create cohorts by diseases and conditions

HIV Management Preventive and treatment-focused HIV program support

• Support pre-exposure prophylaxis (PrEP) preventive treatment and medication programs with HIV core and extended modules
• Extended HIV Module includes additional measures such as Ryan White quality measures and NY State eHIVQual measures for practices with significant HIV populations
• Includes both HIV Lab and HIV Behavioral Health registries
• RSR Reporting Module enables generation of .csv extracts for HRSA Chex tool to prepare annual Ryan White submissions
• Identify patient populations for screenings, diagnosis, and other risk factors
• Incorporate screenings and treatments into the DRVS Pre-Visit Planning report (PVP)
• Support patients through behavioral health and social determinants of health (SDOH) assessments
• Use dashboards to view at-risk and diagnosed populations as well as prevention and treatment program status
• Manage overlapping patient populations with other substance abuse and/or chronic pain conditions
• Create cohorts by diseases and conditions

Analytics & Reporting Integrated registries and measures for program evaluation

• Combination of four registries and 16+ measures for comprehensive data access
• Dashboards to quickly understand the status of various aspects of programs
• Assess the impact of outreach, education and changes to workflow

Benefits

Improved Patient Outcomes Enhanced identification and intervention for at-risk populations

• Early detection enables timely intervention and treatment initiation
• Comprehensive monitoring supports better medication management and adherence
• Behavioral health and SDOH assessments address root causes of substance use
• Overlapping population management ensures coordinated care for complex patients

Operational Efficiency Streamlined program management and resource allocation

• Consolidated data reduces time spent navigating multiple systems
• Automated registries and measures ease the burden of reporting
• Dashboards provide quick status updates on program performance
• Workflow changes can be evaluated for effectiveness

Regulatory Compliance & Quality Support for mandated reporting and quality initiatives

• Facilitates compliance with substance use disorder and HIV treatment reporting requirements
• Supports Ryan White program reporting through RSR Reporting Module
• Enables tracking of quality measures specific to substance use and infectious disease management
• Supports NCQA requirements for population health management

Program Evaluation Data-driven insights for program improvement

• Measure performance across screening, diagnosis, treatment, and cure phases
• Identify barriers to treatment and address them systematically
• Track outcomes of outreach and education efforts
• Monitor success of OBOT and other specialized treatment programs